We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FINAL RULE CATEGORIZES FUNGAL ASSAYS AS CLASS II
FINAL RULE CATEGORIZES FUNGAL ASSAYS AS CLASS II
October 1, 2004
The FDA published a final rule Sept. 23 designating beta-glucan serological assays as class II devices.